| scholarly article | Q13442814 |
| P2093 | author name string | Michihisa Jougasaki | |
| Tomoko Ichiki | |||
| John C. Burnett | |||
| Brenda K. Huntley | |||
| Sharon M. Sandberg | |||
| Paul M. McKie | |||
| Fernando L. Martin | |||
| Denise M. Heublein | |||
| P2860 | cites work | Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme | Q22254421 |
| Furin-mediated Processing of Pro-C-type Natriuretic Peptide | Q28203022 | ||
| Processing of pro-atrial natriuretic peptide by corin in cardiac myocytes | Q28506034 | ||
| Adenovirally encoded prohormone convertase-1 functions in atrial myocyte large dense core vesicles | Q28578319 | ||
| Simultaneous assessment of unprocessed ProBNP1-108 in addition to processed BNP32 improves identification of high-risk ambulatory patients with heart failure | Q33526958 | ||
| Mechanisms and models in heart failure: A combinatorial approach | Q33723469 | ||
| Corin, a mosaic transmembrane serine protease encoded by a novel cDNA from human heart | Q33862279 | ||
| Plasma soluble corin in patients with heart failure. | Q33887635 | ||
| Localization of the mosaic transmembrane serine protease corin to heart myocytes | Q33925569 | ||
| Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure | Q34161199 | ||
| A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats | Q34281894 | ||
| Identification of domain structures in the propeptide of corin essential for the processing of proatrial natriuretic peptide | Q34326399 | ||
| The ABC's (and XYZ's) of peptide sequencing | Q34344848 | ||
| Corin variant associated with hypertension and cardiac hypertrophy exhibits impaired zymogen activation and natriuretic peptide processing activity | Q34803094 | ||
| Plasma brain natriuretic peptide concentration: impact of age and gender | Q34843144 | ||
| Membrane guanylyl cyclase receptors: an update | Q36525043 | ||
| The role of ethylenediamine tetraacetic acid (EDTA) as in vitro anticoagulant for diagnostic purposes. | Q36813298 | ||
| Biosynthesis of cardiac natriuretic peptides | Q37622095 | ||
| Diagnostic importance of changes in circulating concentrations of immunoreactive trypsin | Q39442426 | ||
| Risk factors for cardiovascular disease in women: assessment and management | Q41164428 | ||
| Rat corin gene: molecular cloning and reduced expression in experimental heart failure | Q44904436 | ||
| Evidence for functional heterogeneity of circulating B-type natriuretic peptide. | Q45974538 | ||
| Pro-B-type natriuretic peptide levels in acute decompensated heart failure | Q46604846 | ||
| Autocrine role for the endothelin-B receptor in the secretion of adrenomedullin | Q48007234 | ||
| Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure | Q48093809 | ||
| A new natriuretic peptide in porcine brain | Q48100804 | ||
| Immunoreactivity and guanosine 3',5'-cyclic monophosphate activating actions of various molecular forms of human B-type natriuretic peptide | Q48235282 | ||
| Des-serine-proline brain natriuretic peptide 3-32 in cardiorenal regulation | Q48386405 | ||
| Impact of age and sex on plasma natriuretic peptide levels in healthy adults | Q48541147 | ||
| Role for precursor Pro-B type natriuretic peptide in assessing response to therapy and prognosis in patients with decompensated heart failure treated with nesiritide | Q48572516 | ||
| The circulating levels of cardiac natriuretic hormones in healthy adults: effects of age and sex. | Q48583587 | ||
| Assay for measurement of intact B-type natriuretic peptide prohormone in blood | Q48598797 | ||
| Stretch-induced hypertrophic growth of cardiocytes and processing of brain-type natriuretic peptide are controlled by proprotein-processing endoprotease furin | Q48637180 | ||
| Influence of age on natriuretic peptides in patients with chronic heart failure: a comparison between ANP/NT-ANP and BNP/NT-proBNP. | Q49158567 | ||
| Atrial natriuretic peptide elevation in congestive heart failure in the human | Q69987259 | ||
| Purification of recombinant soluble forms of furin produced in Chinese hamster ovary cells | Q72519342 | ||
| Reference values for plasma dipeptidyl-peptidase IV activity and their association with other laboratory parameters | Q73849022 | ||
| The role of the circulation in processing pro-brain natriuretic peptide (proBNP) to amino-terminal BNP and BNP-32 | Q74072494 | ||
| Processing-independent analysis for pro-C-type natriuretic peptide | Q84960166 | ||
| Pro-B-Type natriuretic peptide: a novel, specific biomarker for detection of left ventricular dysfunction in the general community | Q93551191 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 40-47 | |
| P577 | publication date | 2010-11-12 | |
| P1433 | published in | Clinical Chemistry | Q849687 |
| P1476 | title | Corin Is Present in the Normal Human Heart, Kidney, and Blood, with Pro–B-Type Natriuretic Peptide Processing in the Circulation | |
| P478 | volume | 57 |
| Q36011383 | A novel cytoplasmic tail motif regulates mouse corin expression on the cell surface. |
| Q37229313 | Analytical Issues with Natriuretic Peptides - has this been Overly Simplified? |
| Q51308161 | Association Between High Serum Soluble Corin and Hypertension: A Cross-Sectional Study in a General Population of China. |
| Q41441066 | Association between serum soluble corin and obesity in Chinese adults: a cross-sectional study |
| Q34369603 | BNP molecular forms and processing by the cardiac serine protease corin |
| Q55363721 | Brain Natriuretic Peptide and Its Biochemical, Analytical, and Clinical Issues in Heart Failure: A Narrative Review. |
| Q37076096 | Cardiac-Secreted Factors as Peripheral Metabolic Regulators and Potential Disease Biomarkers. |
| Q92486325 | Circulating NT-proBNP but not soluble corin levels were associated with preeclampsia in pregnancy-associated hypertension |
| Q35634038 | Corin in clinical laboratory diagnostics |
| Q34396853 | Corin in natriuretic peptide processing and hypertension |
| Q34325650 | Corin mutation R539C from hypertensive patients impairs zymogen activation and generates an inactive alternative ectodomain fragment |
| Q33793053 | Corin mutations K317E and S472G from preeclamptic patients alter zymogen activation and cell surface targeting. [Corrected] |
| Q37058407 | Corin overexpression improves cardiac function, heart failure, and survival in mice with dilated cardiomyopathy |
| Q46744986 | Diagnostic utility of BNP, corin and furin as biomarkers for cardiovascular complications in type 2 diabetes mellitus patients. |
| Q36528021 | Differential expression of the pro-natriuretic peptide convertases corin and furin in experimental heart failure and atrial fibrosis |
| Q34450973 | Distinct roles of N-glycosylation at different sites of corin in cell membrane targeting and ectodomain shedding. |
| Q34695497 | Ectodomain shedding and autocleavage of the cardiac membrane protease corin |
| Q92879308 | Emerging concepts of receptor endocytosis and concurrent intracellular signaling: Mechanisms of guanylyl cyclase/natriuretic peptide receptor-A activation and trafficking |
| Q91811322 | Expression and Secretion of an Atrial Natriuretic Peptide in Beige-Like 3T3-L1 Adipocytes |
| Q35154172 | Glycosylation and processing of pro-B-type natriuretic peptide in cardiomyocytes. |
| Q24300328 | Human corin isoforms with different cytoplasmic tails that alter cell surface targeting |
| Q47693539 | IL-1β increases urinary corin in patients with primary proteinuric kidney diseases and in 293 cells |
| Q41871544 | Localization of corin and atrial natriuretic peptide expression in human renal segments. |
| Q38254725 | Natriuretic peptide testing in high-risk pregnancy: a preventive opportunity? |
| Q38211333 | Natriuretic peptides in cardiometabolic regulation and disease |
| Q54945407 | Natriuretic peptides system in the pulmonary tissue of rats with heart failure: potential involvement in lung edema and inflammation. |
| Q27004000 | Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics |
| Q35387004 | Plasma corin decreases after coronary artery bypass graft surgery and is associated with postoperative heart failure: a pilot study |
| Q36054705 | Pro-Atrial Natriuretic Peptide: A Novel Guanylyl Cyclase-A Receptor Activator That Goes Beyond Atrial and B-Type Natriuretic Peptides |
| Q35002194 | Pro-B-type natriuretic peptide-1-108 processing and degradation in human heart failure |
| Q38261513 | Rationale and therapeutic opportunities for natriuretic peptide system augmentation in heart failure |
| Q54275293 | Reduced urinary corin levels in patients with chronic kidney disease. |
| Q27022988 | Role of corin and atrial natriuretic peptide in preeclampsia |
| Q39023640 | Role of corin in the regulation of blood pressure |
| Q48117191 | Role of the protease corin in chondrogenic differentiation of human bone marrow-derived mesenchymal stem cells |
| Q36790719 | Secretion of glycosylated pro-B-type natriuretic peptide from normal cardiomyocytes |
| Q33994980 | Secretion of prohormone of B-type natriuretic peptide, proBNP1-108, is increased in heart failure |
| Q37291818 | Serum corin is reduced and predicts adverse outcome in non-ST-elevation acute coronary syndrome |
| Q91597676 | Sex-specific association between soluble corin and metabolic syndrome in Chinese adults |
| Q46799596 | Short-term High-salt Diet Increases Corin Level to Regulate the Salt-water Balance in Humans and Rodents |
| Q38303192 | State of the art of immunoassay methods for B-type natriuretic peptides: An update. |
| Q37873230 | Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones. |